Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dalfampridine: A Medication to Improve Walking in Patients with Multiple Sclerosis (July/August).
Human Umbilical Cord Mesenchymal Stem Cell Therapy on Neuromyelitis Optica.
[Amino acids content in the blood serum of patients with multiple sclerosis.]
Teva and Active Biotech Announce Discontinuation of Higher Doses of Laquinimod in Two Multiple Sclerosis Trials
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis.
Grey matter lesions in MS: From histology to clinical implications.
The Utility of Administrative Data for Surveillance of Comorbidity in Multiple Sclerosis: A Validation Study.
Transverse myelitis in Behçet's disease: a series of 4 cases and review of the literature.
Use and medicalization of marihuana in cancer patients.
Betaferon efficiency indicators in the treatment of relapsing remitting form of multiple sclerosis.
Therapeutic Potential of Fecal Microbiota Transplantation.
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.
Low vitamin D level is associated with higher relapse rate in natalizumab treated MS patients.
Responsiveness and Clinically Meaningful Improvement, According to Disability Level, of Five Walking Measures After Rehabilitation in Multiple Sclerosis: A European Multicenter Study.
Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis.
Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Case report: an orofacial pain patient with spots on the brain-multiple sclerosis versus central systemic lupus erythematosus.
[Clinical study of optic neuritis combined with viral hepatitis].
[The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with Β-interferon 1a (avonex).]
Evaluation of Inner Retinal Layers in Patients with Multiple Sclerosis or Neuromyelitis Optica Using Optical Coherence Tomography.
Structural and Metabolic Features of Two Different Variants of Multiple Sclerosis: A PET/MRI Study.
SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells.
Tau protein concentrations in the cerebrospinal fluid of children with acute disseminated encephalomyelitis.
Perceptions of health status in multiple sclerosis patients and their doctors.
Neurons and T cells: Understanding this interaction for inflammatory neurological diseases.
Pages
« first
‹ previous
…
304
305
306
307
308
309
310
311
312
…
next ›
last »